Enhancement and phenotypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone

Cancer Letters

Volumn 121, Issue 2, 1997, Pages 125-131

  Metzger, Christel ^a   Bannasch, Peter ^a   Mayer, Doris ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Dehydroepiandrosterone; Phenotypic modulation; Rat liver; Tumor promoter

Indexed keywords

CARCINOGEN; CORTICOSTEROID; NITROSOMORPHOLINE; PRASTERONE;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOPHIL; BENIGN TUMOR; CANCER INCIDENCE; CELL LINEAGE; CONTROLLED STUDY; FEMALE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MORPHOMETRICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ADENOMA, LIVER CELL; ANIMALS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; DEHYDROEPIANDROSTERONE; DRUG SYNERGISM; FEMALE; INCIDENCE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NITROSAMINES; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS;

ANIMALIA;

EID: 0031442918     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00341-8     Document Type: Article

References (41)

1. Schwartz A.G., Whitcomb J.M., Nyce J.W., Lewhart M.L., Pashko L.L. Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents. Adv. Cancer Res. 51:1988;391-424.
2. Bellino F.L., Daynes R.A., Hornsby P.J., Lavrin D.H., Nestler J.E. Dehydroepiandrosterone (DHEA) and aging. Ann. N. Y. Acad. Sci. 774:1995;1-350.
3. VY/a) mice by long term treatment with dehydroepiandrosterone. Cancer Res. 51:1979;666-671.
4. Schwartz A.G., Tannen R.H. Inhibition of 7,12-dimethylbenz[a]anthracene- and urethan-induced lung tumor formation in A/J mice by longterm treatment with dehydroepiandrosterone. Carcinogenesis. 2:1981;1335-1337.
5. Nyce J.W., Magee P.N., Hard G.C., Schwartz A.G. Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in BALB/c mice by dehydroepiandrosterone. Carcinogenesis. 5:1984;57-62.
6. Pashko L.L., Hard G.C., Rovito R.J., Williams J.R., Sobel E.L., Schwartz A.G. Inhibition of 7,12-dimethylbenz[a]anthracene-induced skin papillomas and carcinomas by dehydroepiandrosterone and 3-β-methyl-androst-5-en-17-one in mice. Cancer Res. 45:1985;164-166.
7. Moore M.A., Thamavit W., Tsuda H., Sato K., Ichihara A., Ito N. Modifying influence of dehydroepiandrosterone and the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats. Carcinogenesis. 7:1986;311-316.
8. Garcea R., Daino L., Pascale R., Frassetto S., Cozzolino P., Ruggiu M.E., Feo F. Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. Toxicol. Pathol. 15:1987;164-169.
9. Weber E., Moore M.A., Bannasch P. Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone. Carcinogenesis. 9:1988;1191-1195.
10. Boone C.W., Kellogg A.J., Malone W.E. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res. 50:1990;2-9.
11. Gordon G.B., Shantz L.M., Talalay P. Modulation of growth differentiation and carcinogenesis by dehydroepiandrosterone. Adv. Enzyme Regul. 26:1987;355-382.
12. Garcea R., Daino L., Frassetto S., Cozzolino P., Ruggiu M.E., Vannini M.G., Pascale R., Lenzerini L., Simile M.M., Puddu M., Feo F. Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental carcinogenesis. Carcinogenesis. 9:1988;931-938.
13. Prasanna H.R., Hart R.W., Magee P.N. Recent studies on the effect of dehydroepiandrosterone on the metabolism of carcinogens. J. Toxicol. Toxin Rev. 8:1989;121-131.
14. Wu H.-Q., Masset-Brown J., Tweedie D.J., Milewich L., Frenkel R.A., Martin-Wixtrom C., Estabrook R.W., Prough R.A. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P450IVA1 (P-450 1aω) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator. Cancer Res. 49:1989;2337-2343.
15. Prough R.A., Webb S.J., Wu H.-Q., Lapenson D., Waxman D.J. Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolites in rats. Cancer Res. 54:1994;2878-2886.
16. R.A. Prough, H.-Q. Wu, L. Milewich, Effect of dehydroepiandrosterone on rodent liver microsomal, mitochondrial and peroxisomal proteins, in: M. Kalami, W. Regelson (Eds.), The Biological Role of Dehydroepiandrosterone (DHEA), Walter de Gruyter, Berlin, pp. 253-279.
17. Frenkel R.A., Slaughter C.A., Orth K., Moomaw C.R., Hicks S.H., Snyder J.M., Bennett M., Prough R.A., Putman R.S., Milewich L. Peroxisome proliferation and induction of peroxisomal enzymes in mouse and rat liver by dehydroepiandrosterone feeding. J. Steroid Biochem. 35:1990;333-342.
18. Yamada J., Sakuma M., Ikeda T., Fukuda K., Suga T. Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim. Biophys. Acta. 1092:1991;233-243.
19. Rao M.S., Musunuri S., Reddy J.K. Dehydroepiandrosterone-induced peroxisome proliferation in the rat liver. Pathobiology. 60:1992;82-86.
20. Rao M.S., Subbarao V., Kumar S., Yeldandi V., Reddy J.K. Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats. Jpn. J. Cancer Res. 83:1992;1179-1183.
21. Rao M.S., Subbarao V., Yeldandi A.V., Reddy J.K. Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res. 52:1992;2977-2979.
22. Hayashi F., Tamura H., Yamada J., Kasai H., Suga T. Characteristics of hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis. 15:1994;2215-2219.
23. Metzger C., Mayer D., Hoffmann H., Bocker T., Hobe G., Benner A., Bannasch P. Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol. Pathol. 23:1995;591-605.
24. Reddy J.K., Rao M.S. Oxidative DNA-damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat. Res. 214:1989;63-68.
25. P. Bannasch, H. Zerban, Preneoplastic and neoplastic lesions of the rat liver, in: P. Bannasch, W. Gössner (Eds.), Pathology of Neoplasia and Preneoplasia in Rodents, EULEP Color Atlas, Schattauer, Stuttgart, 1994, pp. 18-63.
26. A. Lang, A. Knoblauch, Mosys: Ein System zur Aufnahme von Objekten in histologischen Schnitten mit zusätzlichen statistischen Auswertefunktionen, Seminararbeit, Universität Heidelberg und Fachhochschule Heilbronn, 1986.
27. Armstrong A., Ben G., Sloan M. Ordinal regression models for epidemiologic data. Am. J. Epidemiol. 129:1989;191-204.
28. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Statist. 6:1979;65-70.
29. Statistical Sciences, S-PLUS Version 3.3. StatSci, a division of MathSoft, Inc., Seattle, 1995.
30. Weber E., Moore M., Bannasch P. Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine. Carcinogenesis. 9:1988;1049-1054.
31. Ashby J., Brady A., Elcombe C.R., Elliott B.M., Ishmael J., Odum J., Tugwood J.D., Kettle S., Purchase I.F. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13(Suppl. 2):1994;S1-S117.
32. Capen C.C., Dayan A.D., Green S. Receptor-mediated mechanisms in carcinogenesis: an overview. Mutat. Res. 333:1995;215-224.
33. Cattley R.C., Miller R.T., Corton J.C. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development. Prog. Clin. Biol. Res. 391:1995;295-303.
34. Yamasaki H., Ashby J., Bignami M., Jongen W., Linnainmaa K., Newbold R.F., Nguyen-Ba G., Parodi S., Rivedal E., Schiffmann D., Simons J.W.I.M., Vasseur P. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. Mutat. Res. 353:1996;47-63.
35. Hobe G., Hillesheim H.G., Schön R., Reddersen G., Knappe R., Bannasch P., Mayer D. Sex differences in dehydroepiandrosterone metabolism in the rat: different plasma levels following ingestion of DHEA-supplemented diet and different metabolite patterns in plasma, bile and urine. Horm. Metab. Res. 26:1994;326-329.
36. G. Hobe, H.G. Hillesheim, R. Schön, G. Ritter, G. Reddersen, D. Mayer, P. Bannasch, Sex differences in dehydroepiandrosterone (DHEA) metabolism in the rat, in: S. Görög (Ed.), Proceedings of the 5th Symposium on the Analysis of Steroids, Akademiai Kiado, Budapest, 1994, pp. 383-390.
37. Swierczynski J., Bannasch P., Mayer D. Increase of lipid peroxidation in rat liver microsomes by dehydroepiandrosterone (DHEA) feeding. Biochim. Biophys. Acta. 1315:1996;193-198.
38. Swierczynski J., Mayer D. Increase of lipid peroxidation in rat liver mitochondria by dehydroepiandrosterone (DHEA) feeding. J. Steroid Biochem. Mol. Biol. 58:1996;599-603.
39. P. Bannasch, Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes, in: J.L. Boyer, R.K. Ockner (Eds.), Progress in Liver Disease, Chapter 7, W.B. Saunders, Philadelphia, PA, 1996, pp. 161-197.
40. Mayer D., Reuter S., Hoffmann H., Bocker T., Bannasch P. Dehydroepiandrosterone reduces expression of glycolytic and gluconeogenic enzymes in the liver of male and female rats. Int. J. Oncol. 8:1996;1069-1078.
41. N. Ito, T. Shirai, R. Hasegawa, Medium-term bioassays for carcinogens, in: H. Vainio, P.N. Magee, D.B. McGregor, A.J. McMichael (Eds.), Mechanisms of Carcinogenesis in Risk Identification, IARC, Lyon, 1992, pp. 353-388.